4Manette T, Jmes B,Mark H, et al. Zidovudine treatment in patients with primary (acute) human immunodeficiency virus type 1 injection :A randomized,double-blind,placebo-controlled trial. J Infect Dis,1998,178:80.
5Gadi B,Dominique A,Marka W, et al. The thicarboxanilide nonnucleoside inhibitor UC781 restores antiviral activity of (AZT)againt AZT-resistant human immunodeficiency virus type 1. Antimicrob Agent Chemother, 1999,43(2) :259.
6Mairtin M ,Marcus C,Arlene H, et al. A preliminary evaluatinn of nelfinavir melfinavir mesylate,an inhibitor of human immunodeficiency virus(HIV)-1 protease to treat HIV infection. J Infer Dis,1998,177:1533.
7Amilcar T ,Anac P,Koko O, et al. Getic variation and susceptibilities to protease inihibitors among subtype B and F isolates in brazil. Antimicrob Agent Chemother, 1999,43 (2): 253.
8Scrip, No. 2743,2002,3:19.
9Chan D C, Fass D, Berger J M, et al. Core structure of gp41 from the HIV envelope glycoprotein[J]. Cell, 1997,B9: 263.
10Jiang S, Lin K, Zhang L, et al. A screening assay for antiviral compounds targeted to the HIV-1 gp41 core structure using a conformation-specific monoclonal antibody[J]. J Virol Methods, 1999,80 : 85.
